Amgen Patents For Cholesterol Drug Valid, Jury Finds
A Delaware federal jury found that two Amgen Inc. patents for a cholesterol drug were valid, handing the California-based pharmaceutical giant victory over rivals Sanofi SA and Regeneron Pharmaceuticals Inc., Amgen...To view the full article, register now.
Already a subscriber? Click here to view full article